jnj-47910382
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2011 (NCT01482611)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Hepatitis C virusINHIBITOR
Hepatitis C virus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- jnj-47910382
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01651767 | Phase 1 | Aug 1, 2012 | Janssen Pharmaceutica NV, Johnson and Johnson |
| NCT01662661 | Phase 1 | Jul 1, 2012 | Johnson and Johnson |
| NCT01586325 | Phase 1 | May 1, 2012 | Janssen Pharmaceutica NV, Johnson and Johnson |
| NCT01482611 | Phase 1 | Nov 1, 2011 | Janssen Pharmaceutica NV, Johnson and Johnson |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johnson and Johnson | For profit | 4 | 4 | 1 | 2011 |
| Janssen Pharmaceutica NV | For profit | 3 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1